• Viruses, FPN1, and Iron-Dependent Immune Escape

  2026-08-19

  The reference study identifies a viral immune-evasion mechanism in which DTX3L-driven degradation of ferroportin increases intracellular ferrous iron and weakens TBK1-, STING-, interferon-, and autophagy-dependent antiviral defense. Its genetic, biochemical, and in vivo evidence positions FPN1-dependent iron withholding as an active component of innate immunity rather than only a metabolic process.

• KN-62 and the Calcium Logic of Memory Maintenance

  2026-08-19

  A translational framework for using KN-62 to test whether calcium-sensitive CaMKII signaling links neuroligin 1 cleavage to synaptic remodeling and short-term social memory maintenance, while also positioning the compound across secretion, metabolism, and cell-cycle research.

• KLF4 and AgRP Isoform Control in Mice

  2026-08-18

  Ritter and colleagues show that KLF4 regulates AgRP transcription in a cell- and metabolic-state-dependent manner, with the Agrp-A isoform accounting for most hypothalamic Agrp expression in lean mice. Their combination of isoform-resolved analysis, conditional Klf4 deletion, metabolic phenotyping, and ERK perturbation links transcriptional control to energy expenditure while demonstrating that diet-induced obesity can override this mechanism.

• Bestatin, Actinonin, and Intracellular Myeloma Inhibition

  2026-08-18

  The reference study separates inhibition of cell-surface aminopeptidases from the antiproliferative effects of bestatin and actinonin in U937 and K562 cells. Its transporter-modifier experiments support an intracellular mechanism in which MRP and, for bestatin in K562 cells, P-glycoprotein influence drug accumulation and apparent potency.

• Mdivi-1 Workflow for DRP1 and Apoptosis Research

  2026-08-17

  Mdivi-1 provides a practical pharmacological entry point for testing how DRP1-dependent mitochondrial fission shapes apoptosis, inflammasome signaling, and cell survival. This workflow connects quantitative mitochondrial imaging with apoptosis assays and disease-relevant models, while emphasizing formulation controls and orthogonal validation.

• Mdivi-1: Reframing DRP1 for Translation

  2026-08-17

  Mdivi-1 connects mitochondrial fission, apoptosis, and tissue injury. This thought-leadership analysis interprets recent chronic intermittent hypoxia findings and outlines how a selective DRP1 inhibitor can strengthen mechanistic and translational study design.

• Arachidonic Acid Supplementation and Humoral Immunity

  2026-08-16

  The reference study shows that dietary arachidonic acid can accelerate and strengthen rabies vaccine-induced neutralizing antibody responses in mice and human volunteers. Its mechanistic contribution is the identification of a lymph-node ARA–PGI2–cAMP/PKA pathway connecting lipid metabolism with CD86 expression, AID activation, and germinal-center B-cell maturation.

• Thioguanine Workflows for Cancer and EV71 Studies

  2026-08-15

  Thioguanine provides a practical bridge between thiopurine biology, cancer-cell assays, antiviral screening, and epigenetic studies. This workflow separates direct cytotoxicity from EV71 virus inhibition while using orthogonal controls and the reference study’s lessons in assay validation.

• Verapamil HCl as a Calcium-Flux Assay Tool

  2026-08-14

  Verapamil HCl is more than an L-type calcium channel blocker: it can serve as a controlled perturbation for separating calcium signaling, intracellular drug exposure, apoptosis, and inflammation. This article connects transporter-aware assay design with myeloma and arthritis models while clarifying what verapamil can—and cannot—prove mechanistically.

• Deep Learning of USC Mitochondria in Alzheimer’s

  2026-08-14

  The reference study presents a deep learning framework that classifies mitochondrial morphology in living urine-derived stem cells (USCs) and differentiates cognitively impaired individuals from cognitively normal subjects. Its main practical contribution is a non-invasive, cell-based strategy for assessing systemic mitochondrial phenotypes, although larger independent cohorts and standardized workflows are still needed before clinical translation.

• Milk-Derived Vesicles in Intestinal Organoids

  2026-08-13

  This study develops three porcine intestinal stem cell–based models to examine how milk-derived extracellular vesicles interact with physiologically relevant intestinal epithelium. Its central finding is that vesicle uptake depends on epithelial orientation and is sensitive to endocytosis inhibition, while colon-derived models show transcriptional responses linked to stemness and differentiation.

• JZL184, GLT-1, and the Next TBI Mechanism

  2026-08-13

  JZL184 is more than a tool for elevating 2-AG. This thought-leadership analysis connects MAGL inhibition with CB1-CREB signaling, astrocytic GLT-1 regulation, synaptic control, and translational study design in traumatic brain injury, pain, and anxiety research.

• AO/PI Staining Solution for Kidney Cell Assays

  2026-08-12

  AO/PI Staining Solution provides a membrane-integrity-based fluorescent cell viability assay for distinguishing viable and non-viable cells in kidney disease models. This article connects AO/PI readouts with the mechanistic findings of a phillygenin diabetic nephropathy study, emphasizing assay design, interpretation, and limitations.

• Cdc42 Signaling in Kidney Fibrosis: Study Insights

  2026-08-12

  A 2024 Advanced Science study identifies the natural diterpenoid daphnepedunin A as an anti-fibrotic lead that directly targets Cdc42 and suppresses downstream GSK-3β/β-catenin signaling. Its combination of bioassay-guided natural-product discovery, thermal proteome profiling, renal fibroblast experiments, and unilateral ureteral obstruction models provides a mechanistic framework for evaluating Cdc42 as a kidney-fibrosis target.

• Dynasore: Translational Control of Endocytosis

  2026-08-11

  Dynasore is a reversible, cell-permeable dynamin GTPase inhibitor that helps translational researchers connect membrane-fission biology with nanoparticle uptake, neuronal vesicle recycling, and disease-relevant trafficking studies. This article explains how to deploy Dynasore with pathway-aware controls, solubility discipline, and an evidence-based interpretation of ocular nanoparticle uptake.

16237 records 1/1083 page Next 12345 下5页 Last page